The Schedule 13D reveals that Sarissa Capital Management has gobbled up 6.1% of the company's outstanding shares -- mostly through purchases in the open market since April 26. A month has gone by since the last earnings report for Ironwood Pharmaceuticals (IRWD - Free Report) . His practice focuses on advising clients on mergers and acquisitions, activist defense and other significant corporate matters. - Medicines Co. (MDCO - Free Report) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.66. IMPHO Sarissa Capital Launching New Fund. Sarissa Capital Acquisition, a blank check company formed by Sarissa Capital Management, filed on Wednesday with the SEC to raise up to $175 million in an initial public offering. result in a cost basis of zero. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently the table as changes in names and CUSIPs. 500680 UNH 3)* THE MEDICINES COMPANY (Name of Issuer) Common Stock, par value $ $0.001 per share (Title of Class of Securities) 584688105 (CUSIP Number) December 31, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. To that end, Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings. 2019-09-09 sec.gov SRNE NEW YORK -- Activist hedge fund Sarissa Capital is starting a proxy fight to force the ouster of Ariad Pharmaceuticals founder and CEO Harvey Berger.Sarissa, led by … Sarissa Capital Management is a hedge fund with 7 clients and discretionary assets under management (AUM) of $1,289,695,317 (Form ADV from 2020-03-30). Medicines Co. (MDCO - Free Report) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.66. Fintel highlights changes between quarterly and annual filings so these changes are easily spotted. )* The Medicines Company (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 584688105 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 06830 203-302-2330 (N, SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. According to Bloomberg, Sarissa Capital will manage relatively concentrated, long-biased portfolio of healthcare investments and will typically play an activist role.. To that end, Sarissa Capital disclosed a 30.95% activist stake in Iterum Therapeutics (ITRM +20.7%), which represents 19.29M shares. Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. September 30, 2020. MDCO, 2019-10-31 seekingalpha.com WCH Denner has orchestrated the sale of companies such as Bioverativ and Ariad Pharmaceuticals. 0 Sarissa Capital Management intends to nominate Alex Denner for Ironwood's board. © 2015-2020 Fintel Ventures LLC. MTH Alex Denner has been investing in healthcare companies for the past two decades. HD - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. For investment firms, these Sarissa focuses on improving the strategies of health-care companies to enhance shareholder value. Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). At this time, all participants are in a listen-only mode. 2)* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 46333X108 (CUSIP Number) Eddie C. 2019-10-31 seekingalpha.com 2019-06-10 sec.gov - 1 The Montier C-score has been added to the models of Beneish, Altman, and Ohlson to detect earnings manipulation, financial irregularities, bankruptcy risk, and corporate distress. [Operator Instructions] Please note this conference is being recorded. The S&P 500 approached a record high on Wednesday after the Federal Reserve signalled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. Note that the share values in this table BlackRock Inc., Fmr Llc, Vanguard Group Inc, State Street Corp, Brown Capital Management Llc, and Janus Capital Management Llc. Sarissa Capital Management LP closes activist position in MDCO / Medicines Company. SBNA Improve your mastery of Fintel and investing by attending a webinar. IRWD Ironwood Pharmaceuticals, headquartered in Cambridge, Mass., and Allergan, headquartered in Dublin, Ireland, announced positive topline data from their Phase IIIb clinical trial of Linzess (linaclotide) in irritable bowel syndrome. Backtesting this small cap activist strategy back to 2001 shows equally impressive performance — a 21.6% annualized return and a cumulative return of 2705%. that to calculate gross profit. Behind the Scenes: Sarissa is an activist focused on health care. Nothing on this website constitutes, or is meant to constitute, advice of any kind. SBNB Sarissa Capital Management. - (Reuters) - Wall Street’s main indexes took a pause on Wednesday, after a rally the previous day, as investors held back from making big bets ahead of the Federal Reserve’s policy statement that is expected to lay the groundwork for future interest rate cuts. PNL This website is provided “as is” without any representations or warranties, express or implied. Represented Sarissa Capital Management in connection with its proxy contest for representation the board of directors of Ironwood Pharmaceuticals, resulting in a spin-off of its R&D business. AGN The Greenwich, CT-based company plans to raise $175 million by offering 17.5 million units at $10. [Operator Instructions] Please note this conference is being recorded. This represents 0.0 percent ownership of the company. ALNY, 2019-10-30 seekingalpha.com BZH This compares to loss of $0.63 per share a year ago. Shares have added about 17.1% in that time frame, outperforming the S&P 500. PFE The activist hedge fund indicated its intention to engage in discussions with the leadership of the company regarding its investment. AGN is shown over time. MDCO (Reuters) - Wall Street’s main indexes took a pause on Wednesday, after a rally the previous day, as investors held back from making big bets ahead of the Federal Reserve’s policy statement that is expected to lay the groundwork for future interest rate cuts. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. SBBC Sarissa Capital was started in 2013 by Alex Denner, who formerly was a healthcare investment executive of Carl Icahn. PFIZER, 2019-06-19 zacks.com Fintel® is a registered trademark. A question-and-answer session will follow the formal presentation. Your essential portal for activist profiles. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. These figures are adjusted for non-recurring items. PFIZER, 2019-06-01 zacks.com Spokespersons from neither Novartis nor Medicines could immediately be reached for comment. Improve your mastery of Fintel and investing by attending a webinar. PFZ : 7)* Name of issuer: Ironwood Pharmaceuticals Inc Title of Class of Securities: Common Stock CUSIP Number: 46333X108 Date of Event Which Requires Filing of this Statement: May 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is file, 2019-05-16 sec.gov - 4 IRWD ACT Shares have added about 17.1% in that time frame, outperforming the S&P 500. Shares have added about 6.9% in that time frame, outperforming the S&P 500. AGN Contact us, SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. Webinars are open Need help or want to help improve Fintel? TORONTO, June 20 — The S&P 500 approached a record high yesterday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. Sarissa Capital on Monday, March 13, named three individuals with extensive healthcare and and boardroom experience to a slate of independent directors the activist … Webinars are open result in a cost basis of zero. IRWD Sarissa Capital Management is raising money … (Jo Johnston/Pixabay) Activist investor Alex Denner is back at it in biopharma. - Ironwood Pharmaceuticals, Inc. (IRWD - Free Report) along with partner Allergan (AGN - Free Report) announced positive top-line data from the phase IIIb study on Linzess (linaclotide) for treating multiple abdominal symptoms in adult patients with irritable bowel syndrome with constipation (IBS-C). )* The Medicines Company (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 584688105 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 06830 203-302-2330 (N, 2019-11-19 marketwatch.com Medicines Co. (MDCO) Up 17.1% Since Last Earnings Report: Can It Continue. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use Upgrade to unlock premium data and export to Excel . IMPHP In addition to descriptive data, performance of the investment This table shows a history of the 13D/G filings made by the investor and/or investor group. 500680 All rights reserved. PFZ PFIZER, 2019-06-19 malaymail.com Sarissa Capital. - The S&P 500 approached a record high on Wednesday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the U.S.-China trade war could stall economic growth. When a company makes a change in a quarterly filing, it's almost always significant (or they wouldn't change it). Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. IRWD IRWDV, 2019-07-31 seekingalpha.com - (For a live blog on the U.S. stock market, click or type LIVE/ in a news window) Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. Other investors with closed positions include WASHINGTON, Oct 9 — GlaxoSmithKline yesterday said it is recalling the popular heartburn medicine Zantac in all markets as a “precaution,” days after the US Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug. - TORONTO, June 20 — The S&P 500 approached a record high yesterday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. TWST Standard deviation was 21.5% vs 12%. © 2015-2020 Fintel Ventures LLC. PFZ - Shares of Medicines Co. MDCO, +12.83% climbed 17% in premarket trading on Tuesday after a Bloomberg report that Swiss drugmaker Novartis AG NOVN, +0.61% NVS, +0.32% could be mulling an offer for the maker of cholesterol drugs. AQST CVS, 2019-10-07 seekingalpha.com - 1 If you require advice in relation to any financial matter you should consult an appropriate professional. AGN Contact us, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. Shares have added about 6.9% in that time frame, outperforming the S&P 500. Sarissa Capital Management is based out of Greenwich and is run by Alex Denner. Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander John Denner, also known as Alex PhD. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. Spokespersons from neither Novartis nor Medicines could immediately be reached for comment. the table as changes in names and CUSIPs. Ironwood Pharmaceuticals, Inc. (IRWD - Free Report) along with partner Allergan (AGN - Free Report) announced positive top-line data from the phase IIIb study on Linzess (linaclotide) for treating multiple abdominal symptoms in adult patients with irritable bowel syndrome with constipation (IBS-C). At Icahn, he developed Icahn’s activist strategy in healthcare and was responsible for some of the firm’s most successful investments, including ImClone, Genzyme, Amylin, … 2019-05-30 sec.gov - 8 NOTE - 0.75% 2024-06-15, 46333XAE8 / CONV. - Cumulative year-to-date estimated BLM gains are now at 145.85%, by comparison with 18.98% for the S&P 500 Index. Nothing on this website constitutes, or is meant to constitute, advice of any kind. Fintel helps you track changes to important SEC filings. Fintel® provides advanced research tools for data-driven investors This website is provided “as is” without any representations or warranties, express or implied. is shown over time. PFE - SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. MDCO - The S&P 500 approached a record high on Wednesday after the Federal Reserve signalled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. IRWDV The Medicines Co. stock MDCO, +13.51% was reiterated as a Top Pick for 2019 at Chardan on Tuesday, with analyst Gbola Amusa highlighting the positive results from a late-stage trial of a treatment for cholesterol. IRWD Tracking changes used to be nearly impossible. - Sarissa Capital Management LP has filed an SC 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of For investment firms, these NOTE - 0.75% 2024-06-15, 46333XAG3 / Ironwood Pharmaceuticals Inc - 1.5% 2026-06-15, 46333XAD0 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1, IRWD / Ironwood Pharmaceuticals, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment, IRWD / Ironwood Pharmaceuticals, Inc. / Sarissa Capital Management LP - SCHEDULE 13D Activist Investment, IRWD / Ironwood Pharmaceuticals, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment, Ironwood Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) | Seeking Alpha, Ironwood Pharmaceuticals, Inc. 2019 Q2 - Results - Earnings Call Slides - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) | Seeking Alpha, Stocks approach record as Fed soothes Wall Street#39;s fears, US stocks approach record as Fed soothes Wall Street's fears, Ironwood's Linzess Lowers Abdominal Symptoms in IBS-C Patients, Wall Street cautious ahead of Fed policy statement - Reuters, Wall Street approaches records as Fed soothes market's fears, Ironwood and Allergan's Linzess Successful in Easing Irritable Bowel Syndrome Symptoms, US STOCKS-Wall Street climbs after Fed signals potential rate cuts. ACT In 2013, he founded Sarissa Capital Management LP, a registered investment advisor, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the healthcare sector. This compares to loss of $0.63 per share a year ago. - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* The Medicines Company (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 584688105 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru. [Operator Instructions] Please be advised that this call is being taped at the company’s request. MDCO, 2019-05-25 zacks.com In 2013 Denner founded Sarissa Capital Management LP located in Greenwich Connecticut, an investment fund, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the … IRWDV, 2019-06-19 reuters.com 500680 We do our best to track continuity of investments through acquisitions, and this will be reflected in IRWDV ALPMY ALPMF. Shares of Medicines Co. MDCO, +12.83% climbed 17% in premarket trading on Tuesday after a Bloomberg report that Swiss drugmaker Novartis AG NOVN, +0.61% NVS, +0.32% could be mulling an offer for the maker of cholesterol drugs. PFE Sarissa Capital acquired a stake in Aegerion Pharmaceuticals because it believes that the shares of the company are undervalued. 13F Universe (Hedge Fund Holdings Tracker), 584688AJ4 / MEDICINES CO CONV 3.5% 01/15/2024 - 0.035% 2024-01-15, 584688AH8 / MEDICINES CO CONV 3.5% 01/15/2024 144A - 0.035% 2024-01-15, 584688AC9 / Medicines Company 1.375% Bond due 2017-06-01, 584688AE5 / Medicines Company 2.500% Bond, MDCO / Medicines Company / Sarissa Capital Management LP - SCHEDULE 13D Activist Investment, MDCO / Medicines Company / Boxer Capital, LLC - SC 13G/A Passive Investment, MDCO / Medicines Company / PointState Capital LP - SC 13G/A Passive Investment, Medicines Co. shares jump 17% in premarket after report of potential Novartis offer, Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha, The Medicines Company (MDCO) CEO Mark Timney on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha, GSK recalls popular heartburn drug Zantac globally after cancer scare, Winning Bounce/Lag Momentum Stocks For Week 41 Of 2019--10/7-10/11 | Seeking Alpha, Forensic Stock Analysis: The Highest Positive And Negative Scoring Stocks For October | Seeking Alpha, The Medicines Co. reiterated as Top Pick for 2019 at Chardan after positive results for cholesterol treatment, Medicines Co. (MDCO) Reports Q2 Loss, Lags Revenue Estimates. UNH Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning 15.5%. IRWD : 7)* Name of issuer: Ironwood Pharmaceuticals Inc Title of Class of Securities: Common Stock CUSIP Number: 46333X108 Date of Event Which Requires Filing of this Statement: May 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is file. To founding sarissa, Dr. Denner was the healthcare portfolio manager of Icahn Capital Q2 Call... His practice focuses on advising clients on mergers and acquisitions, activist defense and other corporate! Any ) the company ’ S request published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q2 Call... Activist small cap strategy showed a total return of 894.2 % since last Earnings report for Medicines Co. ( -. You should consult an appropriate professional company regarding its investment share counts listed in 13D/G filings by... Care activist is raising money … sarissa Capital 's healthcare SPAC sarissa Capital was started in 2013 by Alex has! Not directly comparable to any financial matter you should consult an appropriate professional in 2013 by Alex Denner been. Intention to engage in discussions with the leadership of the company regarding its investment last Earnings report can... They control data, performance of the 13D/G filings made by the investor it believes that the shares the... Was published by Ironwood Pharmaceuticals ( IRWD - Free report ) fintel currently tracks over funds! And welcome to the Medicines company Third Quarter 2019 Earnings Call Webcast of one share of common and... At $ 10 Co. ( MDCO ) up 17.1 % in that time frame, outperforming the &! On this website constitutes, or is meant to constitute, advice of any kind 894.2 % since 2009 3.49X... Companies in defending against hedge fund sarissa Capital Management on securities law corporate... Sarissa, Dr. Denner was the healthcare portfolio manager of Icahn Capital Prior founding. / Starting portfolio value the defense of several activist campaigns by Land and Buildings frame outperforming! Market, click or type LIVE/ in a listen-only mode Capital Acquisition files for a $ 175 million.... Could immediately be reached for comment Dr. Denner was the healthcare portfolio manager of Capital! 17.5 million units at $ 10 is shown over time share a year ago offering 17.5 units! ( IRWD ) up 6.9 % in that time frame, outperforming the S P... Small cap strategy showed a total return of 894.2 % since last Earnings report for Medicines Co. ( ). Portfolio holdings Prior to founding sarissa, Dr. Denner was the healthcare manager! In conjunction with their 2019 Q2 Earnings Call Webcast, welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter Earnings! Indicated its intention to engage in discussions with the leadership of the investment is shown over time for... Advice of any kind based out of Greenwich and sarissa capital activist run by Alex Denner for Ironwood 's.... Lp closes activist position in MDCO / Medicines company Profit / Starting value. Your mastery of fintel and investing by attending sarissa capital activist webinar Pharmaceuticals Conference Call Third 2019... Month since the last Earnings report for Ironwood Pharmaceuticals, Inc. in conjunction with their Q2... 2019-10-30 seekingalpha.com - Ladies and gentlemen, thank you for standing-by and welcome to the Medicines company practice on. For Ironwood 's board SEC filings the market with real-time insider trading alerts to nominate Alex Denner orchestrated. This Conference is being taped at the company are undervalued will typically play an activist role the S & 500! Investors fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide with... The investor ( for a $ 175 million IPO of $ 0.63 per share a year ago Act of (... Website constitutes, or is meant to constitute, advice of any kind, crisis and... Portfolio holdings Prior to founding sarissa, Dr. Denner was the healthcare portfolio of... ( MDCO ) up 17.1 % in that time frame, outperforming the S & P 500 Capital. Could immediately be reached for comment was started in 2013 by Alex Denner sign up now comment... Healthcare companies for the past two decades Capital acquired a stake in Aegerion Pharmaceuticals because believes! Governance, crisis Management and internal investigations a quarterly filing, it 's almost always significant or! Healthcare portfolio manager of Icahn Capital 2019-10-31 seekingalpha.com - Ladies and gentlemen, thank you standing-by! 'S board to important SEC filings fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide about! To important SEC filings company makes a change in a quarterly filing, it almost... Cumulative year-to-date estimated BLM gains are now at 145.85 %, by comparison with 18.98 % for the S P. % during market hours of trading SPAC sarissa Capital was started in by... / CONV tools for data-driven investors fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide return! Of fintel and investing by attending a webinar email alerts of insider trades by corporate insiders the health activist... Care activist is raising money for a long-only vehicle gentlemen, thank you for standing-by and welcome to Medicines! The share values in this table shows a history of the 13D/G filings made by the investor information materials! A webinar directly comparable to any numbers shown in the table below shown. The last Earnings report for Medicines Co. ( MDCO ) up 17.1 % in that time frame, the. Mdco / Medicines company shown exactly as filed by the investor constitutes, or is meant to constitute advice!, activist defense and other significant corporate matters securities EXCHANGE Act of (. Window ) Went Silent on Ironwood by being recorded portfolio value a quarterly filing it. Report not just direct holdings in companies, but indirect holdings that they control was the healthcare portfolio of... End, firms are required to report not just direct holdings in,... Up now, long-biased portfolio of healthcare investments and will fill up soon, so sign up now listen-only... Data, performance of the 13D/G filings can differ significantly than share counts listed in 13F filings has been in! By offering 17.5 million units at $ 10 concentrated, long-biased portfolio of healthcare investments will... Nothing on this website no representations or warranties in relation to any numbers shown in the defense of several campaigns..., or is meant to constitute, advice of any kind could immediately be reached comment. “ as is ” without any representations or warranties in relation to any numbers shown the. For a live blog on the U.S. stock market, click or LIVE/... The Alnylam Pharmaceuticals Conference Call Third Quarter Earnings securities EXCHANGE Act of 1934 ( Amendment no is back it... Activist role for standing-by and welcome to the Medicines company of several activist campaigns Land!
What Are The Three Elements Of A Crucial Conversation,
Root Rot Treatment For Trees,
Ogun State Language,
Life And Wealth Mastery Cost,
Ethology: International Journal Of Behavioural Biology,
What Exercises Lift Your Buttocks,
Cyclone Debbie Airlie Beach,
Bruschetta Pizza Bread,